Intra-aortic balloon counterpulsation - Basic principles and clinical evidence

Vascular Pharmacology

Volumn 60, Issue 2, 2014, Pages 52-56

  De Waha, Suzanne ^a   Desch, Steffen ^a   Eitel, Ingo ^a   Fuernau, Georg ^b   Lurz, Philipp ^a   Sandri, Marcus ^a   Schuler, Gerhard ^a   Thiele, Holger ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Basic principles; Clinical evidence; Intra aortic balloon pump counterpulsation

Indexed keywords

PRASUGREL; TICAGRELOR;

ACUTE HEART INFARCTION; BLEEDING; BRAIN ISCHEMIA; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; COUNTERPULSATION; HEPARINIZATION; HIGH RISK PATIENT; HUMAN; INTRA AORTIC BALLOON COUNTERPULSATION; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; LIMB ISCHEMIA; MEDICAL DEVICE COMPLICATION; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; THROMBOCYTOPENIA; VASCULAR ACCESS; VASCULAR DISEASE;

BASIC PRINCIPLES; CLINICAL EVIDENCE; INTRA-AORTIC BALLOON PUMP COUNTERPULSATION;

ANIMALS; CORONARY ARTERY BYPASS; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 84893802995     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.12.003     Document Type: Review

References (56)

1. Schiariti M., Saladini P., Cuturello D., Iannetta L., Torromeo C., Puddu P.E. Decline in platelet count and long-term post-PCI ischemic events: implication of the intra-aortic balloon pump. Vascul Pharmacol 2014, 60(1):25-31.
2. Kern M.J., Aguirre F., Bach R., Donohue T., Siegel R., Segal J. Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 1993, 87(2):500-511.
3. Williams D.O., Korr K.S., Gewirtz H., Most A.S. The effect of intraaortic balloon counterpulsation on regional myocardial blood flow and oxygen consumption in the presence of coronary artery stenosis in patients with unstable angina. Circulation 1982, 66(3):593-597.
4. Scheidt S., Wilner G., Mueller H., Summers D., Lesch M., Wolff G., Krakauer J., Rubenfire M., Fleming P., Noon G., Oldham N., Killip T., Kantrowitz A. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 1973, 288(19):979-984.
5. Prondzinsky R., Unverzagt S., Russ M., Lemm H., Swyter M., Wegener N., Buerke U., Raaz U., Ebelt H., Schlitt A., Heinroth K., Haerting J., Werdan K., Buerke M. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 2012, 37(4):378-384.
6. Davidson J., Baumgartner F., Omari B., Milliken J. Intra-aortic balloon pump: indications and complications. J Natl Med Assoc 1998, 90(3):137-140.
7. Patel J.J., Kopisyansky C., Boston B., Kuretu M.L., McBride R., Cohen M. Prospective evaluation of complications associated with percutaneous intraaortic balloon counterpulsation. Am J Cardiol 1995, 76(16):1205-1207.
8. Fuchs S., Stabile E., Kinnaird T.D., Mintz G.S., Gruberg L., Canos D.A., Pinnow E.E., Kornowski R., Suddath W.O., Satler L.F., Pichard A.D., Kent K.M., Weissman N.J. Stroke complicating percutaneous coronary interventions: incidence, predictors, and prognostic implications. Circulation 2002, 106(1):86-91.
9. Rao S.V., Jollis J.G., Harrington R.A., Granger C.B., Newby L.K., Armstrong P.W., Moliterno D.J., Lindblad L., Pieper K., Topol E.J., Stamler J.S., Califf R.M. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292(13):1555-1562.
10. Cooper H.A., Thompson E., Panza J.A. The role of heparin anticoagulation during intra-aortic balloon counterpulsation in the coronary care unit. Acute Card Care 2008, 10(4):214-220.
11. Pucher P.H., Cummings I.G., Shipolini A.R., McCormack D.J. Is heparin needed for patients with an intra-aortic balloon pump?. Interact Cardiovasc Thorac Surg 2012, 15(1):136-139.
12. Hirsh J., Anand S.S., Halperin J.L., Fuster V. Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation 2001, 103(24):2994-3018.
13. Stegman B.M., Newby L.K., Hochman J.S., Ohman E.M. Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment is therapeutic hypothermia one possibility?. J Am Coll Cardiol 2012, 59(7):644-647.
14. Reynolds H.R., Hochman J.S. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008, 117(5):686-697.
15. Thiele H., Allam B., Chatellier G., Schuler G., Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials?. Eur Heart J 2010, 31(15):1828-1835.
16. Achour H., Boccalandro F., Felli P., Amirian J., Uthman M., Buja M., Smalling R.W. Mechanical left ventricular unloading prior to reperfusion reduces infarct size in a canine infarction model. Catheter Cardiovasc Interv 2005, 64(2):182-192.
17. Azevedo C.F., Amado L.C., Kraitchman D.L., Gerber B.L., Edvardsen T., Osman N.F., Rochitte C.E., Wu K.C., Lima J.A. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J 2005, 26(12):1235-1241.
18. LeDoux J.F., Tamareille S., Felli P.R., Amirian J., Smalling R.W. Left ventricular unloading with intra-aortic counter pulsation prior to reperfusion reduces myocardial release of endothelin-1 and decreases infarction size in a porcine ischemia-reperfusion model. Catheter Cardiovasc Interv 2008, 72(4):513-521.
19. O'Rourke M.F., Norris R.M., Campbell T.J., Chang V.P., Sammel N.L. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol 1981, 47(4):815-820.
20. Flaherty J.T., Becker L.C., Weiss J.L., Brinker J.A., Bulkley B.H., Gerstenblith G., Kallman C.H., Weisfeldt M.L. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol 1985, 6(2):434-446.
21. Kono T., Morita H., Nishina T., Fujita M., Onaka H., Hirota Y., Kawamura K., Fujiwara A. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol 1996, 28(4):876-881.
22. Ohman E.M., George B.S., White C.J., Kern M.J., Gurbel P.A., Freedman R.J., Lundergan C., Hartmann J.R., Talley J.D., Frey M.J., et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The randomized IABP study group. Circulation 1994, 90(2):792-799.
23. Stone G.W., Marsalese D., Brodie B.R., Griffin J.J., Donohue B., Costantini C., Balestrini C., Wharton T., Esente P., Spain M., Moses J., Nobuyoshi M., Ayres M., Jones D., Mason D., Grines L., O'Neill W.W., Grines C.L. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) trial investigators. J Am Coll Cardiol 1997, 29(7):1459-1467.
24. van't Hof A.W., Liem A.L., de Boer M.J., Hoorntje J.C., Suryapranata H., Zijlstra F. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 1999, 20(9):659-665.
25. Ohman E.M., Nanas J., Stomel R.J., Leesar M.A., Nielsen D.W., O'Dea D., Rogers F.J., Harber D., Hudson M.P., Fraulo E., Shaw L.K., Lee K.L. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 2005, 19(1):33-39.
26. Vijayalakshmi K., Kunadian B., Whittaker V.J., Wright R.A., Hall J.A., Sutton A., Muir D., de Belder M.A. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol 2007, 19(8):339-346.
27. Patel M.R., Smalling R.W., Thiele H., Barnhart H.X., Zhou Y., Chandra P., Chew D., Cohen M., French J., Perera D., Ohman E.M. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA 2011, 306(12):1329-1337.
28. Sjauw K.D., Engstrom A.E., Vis M.M., van der Schaaf R.J., Baan J., Koch K.T., de Winter R.J., Piek J.J., Tijssen J.G., Henriques J.P. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?. Eur Heart J 2009, 30(4):459-468.
29. Bahekar A., Singh M., Singh S., Bhuriya R., Ahmad K., Khosla S., Arora R. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther 2011, 17(1):44-56.
30. Cassese S., de Waha A., Ndrepepa G., Ranftl S., King L., Schomig A., Kastrati A. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials. Am Heart J 2012, 164(1):58-65. [e51].
31. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A., Granger C.B., Krumholz H.M., Linderbaum J.A., Morrow D.A., Newby L.K., Ornato J.P., Ou N., Radford M.J., Tamis-Holland J.E., Tommaso C.L., Tracy C.M., Woo Y.J., Zhao D.X., Anderson J.L., Jacobs A.K., Halperin J.L., Albert N.M., Brindis R.G., Creager M.A., DeMets D., Guyton R.A., Hochman J.S., Kovacs R.J., Ohman E.M., Stevenson W.G., Yancy C.W. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 61(4):e78-e140.
32. Steg P.G., James S.K., Atar D., Badano L.P., Lundqvist C.B., Borger M.A., Di Mario C., Dickstein K., Ducrocq G., Fernandez-Aviles F., Gershlick A.H., Giannuzzi P., Halvorsen S., Huber K., Juni P., Kastrati A., Knuuti J., Lenzen M.J., Mahaffey K.W., Valgimigli M., Van't Hof A., Widimsky P., Zahger D., Bax J.J., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck-Brentano C., Hasdai D., Hoes A., Kirchhof P., Kolh P., McDonagh T., Moulin C., Popescu B.A., Reiner Z., Sechtem U., Sirnes P.A., Tendera M., Torbicki A., Vahanian A., Windecker S., Astin F., Astrom-Olsson K., Budaj A., Clemmensen P., Collet J.P., Fox K.A., Fuat A., Gustiene O., Hamm C.W., Kala P., Lancellotti P., Maggioni A.P., Merkely B., Neumann F.J., Piepoli M.F., Van de Werf F., Verheugt F., Wallentin L. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012, 33(20):2569-2619.
33. Goldberg R.J., Spencer F.A., Gore J.M., Lessard D., Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009, 119(9):1211-1219.
34. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., Lloyd-Jones D., Goff D.C., Hong Y., Adams R., Friday G., Furie K., Gorelick P., Kissela B., Marler J., Meigs J., Roger V., Sidney S., Sorlie P., Steinberger J., Wasserthiel-Smoller S., Wilson M., Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006, 113(6):e85-e151.
35. Zahn R., Schiele R., Schneider S., Gitt A.K., Wienbergen H., Seidl K., Voigtlander T., Gottwik M., Berg G., Altmann E., Rosahl W., Senges J. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol 2001, 37(7):1827-1835.
36. Thiele H., Zeymer U., Neumann F.J., Ferenc M., Olbrich H.G., Hausleiter J., Richardt G., Hennersdorf M., Empen K., Fuernau G., Desch S., Eitel I., Hambrecht R., Fuhrmann J., Bohm M., Ebelt H., Schneider S., Schuler G., Werdan K. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012, 367(14):1287-1296.
37. Thiele H., Zeymer U., Neumann F.J., Ferenc M., Olbrich H.G., Hausleiter J., de Waha A., Richardt G., Hennersdorf M., Empen K., Fuernau G., Desch S., Eitel I., Hambrecht R., Lauer B., Bohm M., Ebelt H., Schneider S., Werdan K., Schuler G. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013, 382(9905):1638-1645.
38. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., Smith S.C. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. Circulation 2004, 110:588-636.
39. Van de Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea F., Falk V., Filippatos G., Fox K., Huber K., Kastrati A., Rosengren A., Steg P.G., Tubaro M., Verheugt F., Weidinger F., Weis M. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008, 29(23):2909-2945.
40. Levine G.N., Bates E.R., Blankenship J.C., Bailey S.R., Bittl J.A., Cercek B., Chambers C.E., Ellis S.G., Guyton R.A., Hollenberg S.M., Khot U.N., Lange R.A., Mauri L., Mehran R., Moussa I.D., Mukherjee D., Nallamothu B.K., Ting H.H. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011, 124(23):e574-e651.
41. Wijns W., Kolh P., Danchin N., Di Mario C., Falk V., Folliguet T., Garg S., Huber K., James S., Knuuti J., Lopez-Sendon J., Marco J., Menicanti L., Ostojic M., Piepoli M.F., Pirlet C., Pomar J.L., Reifart N., Ribichini F.L., Schalij M.J., Sergeant P., Serruys P.W., Silber S., Sousa Uva M., Taggart D. Guidelines on myocardial revascularization. Eur Heart J 2010, 31(20):2501-2555.
42. Mishra S., Chu W.W., Torguson R., Wolfram R., Deible R., Suddath W.O., Pichard A.D., Satler L.F., Kent K.M., Waksman R. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006, 98(5):608-612.
43. Briguori C., Sarais C., Pagnotta P., Airoldi F., Liistro F., Sgura F., Spanos V., Carlino M., Montorfano M., Di Mario C., Colombo A. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003, 145(4):700-707.
44. Brodie B.R., Stuckey T.D., Hansen C., Muncy D. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999, 84(1):18-23.
45. Perera D., Stables R., Thomas M., Booth J., Pitt M., Blackman D., de Belder A., Redwood S. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA 2010, 304(8):867-874.
46. Perera D., Stables R., Clayton T., De Silva K., Lumley M., Clack L., Thomas M., Redwood S. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention. Circulation 2013, 127(2):207-212.
47. Chen S., Yin Y., Ling Z., Krucoff M.W. Short and long term effect of adjunctive intra-aortic balloon pump use for patients undergoing high risk reperfusion therapy: a meta-analysis of 10 international randomised trials. Heart 2013, in press [Epub ahead of print].
48. Romeo F., Acconcia M.C., Sergi D., Romeo A., Gensini G.F., Chiarotti F., Caretta Q. Lack of intra-aortic balloon pump effectiveness in high-risk percutaneous coronary interventions without cardiogenic shock: a comprehensive meta-analysis of randomised trials and observational studies. Int J Cardiol 2013, 167(5):1783-1793.
49. Abramov D., Tamariz M.G., Fremes S.E., Guru V., Borger M.A., Christakis G.T., Bhatnagar G., Sever J.Y., Goldman B.S. Trends in coronary artery bypass surgery results: a recent, 9-year study. Ann Thorac Surg 2000, 70(1):84-90.
50. Ferguson T.B., Hammill B.G., Peterson E.D., DeLong E.R., Grover F.L. A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 2002, 73(2):480-489. [discussion 489-490].
51. Christenson J.T., Badel P., Simonet F., Schmuziger M. Preoperative intraaortic balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surg 1997, 64(5):1237-1244.
52. Christenson J.T., Licker M., Kalangos A. The role of intra-aortic counterpulsation in high-risk OPCAB surgery: a prospective randomized study. J Card Surg 2003, 18(4):286-294.
53. Christenson J.T., Simonet F., Badel P., Schmuziger M. Evaluation of preoperative intra-aortic balloon pump support in high risk coronary patients. Eur J Cardiothorac Surg 1997, 11(6):1097-1103. [discussion 1104].
54. Christenson J.T., Simonet F., Badel P., Schmuziger M. The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left-ventricular function (LVEF<40%), and hypertensive LV hypertrophy. Thorac Cardiovasc Surg 1997, 45(2):60-64.
55. Christenson J.T., Simonet F., Badel P., Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 1999, 68(3):934-939.
56. Marra C., De Santo L.S., Amarelli C., Della Corte A., Onorati F., Torella M., Nappi G., Cotrufo M. Coronary artery bypass grafting in patients with severe left ventricular dysfunction: a prospective randomized study on the timing of perioperative intraaortic balloon pump support. Int J Artif Organs 2002, 25(2):141-146.